Dapasingul Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Adult dose

Take 10 mg once a day for monotherapy and additional combination therapy. For initial combination therapy, take 5 mg or 10 mg once a day. Regardless of food intake, take orally once a day at any time and swallow the tablet whole.

This medicine should not be used in patients with a history of allergic reactions to the active ingredients or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. The drug contains lactose, and should not be used in patients with hereditary conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. It should also not be administered to patients undergoing renal dialysis. Use with caution in patients with reduced fluid volume or poor kidney function, as blood pressure drop or worsening kidney function may occur; the patient's condition should be monitored before and after administration. In patients with moderate to severe reduced kidney function, blood glucose control efficacy may decrease, and this medication is not recommended for patients with very low kidney function. This medication may increase the risk of genital infections and urinary tract infections, so immediate treatment is necessary upon symptoms of infection. When used with insulin or sulfonylureas, which have a risk of hypoglycemia, pay attention to symptoms of low blood sugar, and adjust the dosage of those medications if necessary. There can be signs of dehydration or hypotension due to reduced fluid volume, so caution is needed, especially in elderly patients or those taking diuretics. Diabetic ketoacidosis may occur; if symptoms such as vomiting, abdominal pain, or difficulty breathing appear, inform medical personnel immediately. Pregnant or breastfeeding women should avoid using this medicine, and if pregnancy is confirmed, discontinuation should occur. The safety and efficacy for children have not been established, and it should not be used in pediatric patients. In the event of an overdose, appropriate treatment depending on symptoms is required, and since there is no specific antidote, medical personnel's instructions should be followed. This medication does not significantly affect driving or operating machinery, but caution is necessary in cases where there is a risk of hypoglycemia.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, abnormal breathing with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, dry mouth, dizziness, constipation, back pain, dysuria, polyuria, nocturia, interstitial nephritis, increased hematocrit, reduced renal creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, lightheadedness, herpes simplex, pruritus, hives, cold sweats, chest pain,

This medicine should be stored in a tightly closed container to avoid exposure to air and moisture. It is recommended to maintain storage temperature between 1 to 30 degrees Celsius. This will help preserve the effectiveness of the medication.

Appearance

Yellow, bi-convex, diamond-shaped film-coated tablet

Package unit

PTP - 28 tablets/box [(7 tablets/PTP x 4)], bottle - 30 tablets/bottle